Re:Cognition Health Achieves Global Clinical Site Assessment Recertification at its U.S. Clinics

FAIRFAX, Va., April 29, 2026 /PRNewswire/ -- Re:Cognition Health, a global leader in new treatments for Alzheimer's Disease, is pleased to announce that it has successfully renewed its Global Clinical Site Assessment (GCSA) Site Certification, awarded by the International Accrediting...